ALEMBIC Fundamentals

<div class='circular--portrait' style='background:#FF01C9;color: #FFF8DC;font-size:3em;padding-top: 38px;;'>ALE</div>
ALEMBIC fundamental analysis lookup allows you to check this and other indicators for ALEMBIC LTD or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Fundamentals

 
Refresh

ALEMBIC Market Capitalization Analysis

Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Market Cap 
 = 
Shares Outstanding 
X  
Share Price 
More About Market Capitalization | All Equity Analysis

Current ALEMBIC LTD Market Capitalization

11 B

About Market Capitalization

In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size. Compare to competition
Based on recorded statements the market capitalization of ALEMBIC LTD is about 11 B. This is 15.0% lower than that of the Healthcare sector, and 123.12% higher than that of Drug Manufacturers - Specialty & Generic industry, The Market Capitalization for all stocks is 42.19% higher than the company.

ALEMBIC LTD Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ALEMBIC's current stock value. Our valuation model uses many indicators to compare ALEMBIC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ALEMBIC competition to find correlations between indicators driving ALEMBIC's intrinsic value. More Info.
ALEMBIC LTD is number one stock in beta category among related companies. It is number one stock in return on asset category among related companies reporting about  0.83  of Return On Asset per Beta. The ratio of Beta to Return On Asset for ALEMBIC LTD is roughly  1.20 
ALEMBIC LTD is number one stock in market capitalization category among related companies. Market capitalization of Drug Manufacturers - Specialty & Generic industry is presently estimated at about 22 Billion. ALEMBIC totals roughly 11 Billion in market capitalization claiming about 50% of equities under Drug Manufacturers - Specialty & Generic industry.
Capitalization  Total debt  Valuation  Revenue  Workforce

ALEMBIC Fundamentals



 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page